An Echelon Media Company
Sunday June 20th, 2021
Health

One million more doses of Sinopharm arrive in Sri Lanka

ECONOMYNEXT – Sri Lanka received another million doses of the Sinopharm COVID-19 vaccine in the early hours of June 09 out of a total 13 million the Island is set to purchase from the Chinese manufacturer this year.

The first batch of one million doses arrived on June 06, according to health officials.

Health Minister Pavithra Wanniarachchi told reporters on June 08 that with these consignments Sri Lanka would extend the country’s vaccine rollout to 12 more districts in the coming days.

The health ministry said it will distribute 25,000 doses of Sinopharm each to Matale, Batticaloa, Trincomalee, Ampara, Polonnaruwa, Kurunegala, Puttalam and Monaragala districts and 50,000 doses each to Nuwara Eliya, Hambanthota, Anuradhapura, Badulla and Kegall districts.

So far Sri Lanka has received 3.1 million doses of Sinopharm of which 1.1 million doses were a donation from the Chinese government.

As at June 06, health authorities have administered the Chinese vaccine to 957,959 people.

According to official data, 1,033,028 people have already received the first dose of the Chinese vaccine while only 166 have got the second dose.

The first dose of the India-made AstraZeneca Covishield vaccine has been administered to 925,242 so far, while 353,789 people have received the second dose. Some 600,000 are still awaiting their second dose, with the government reaching out to foreign governments and other parties for any excess stock.

Meanwhile, 64,986 Sri Lankans have received the first dose of the Russian Sputnik V vaccine.

A total 353,955 people in Sri Lanka have received both doses of either Covidshied or Sinopharm, official data shows. (Colombo/June09/2021)

Tags:

Leave a Comment

Your email address will not be published. Required fields are marked *

Your email address will not be published. Required fields are marked *

Comments

Leave a Comment

Your email address will not be published. Required fields are marked *

Your email address will not be published. Required fields are marked *